(Q42969897)

English

Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib

scientific article published on August 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

Europe PubMed Central

Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

author name string

A Wollenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

M Staehler

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

T Eames

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Die Dermatologie

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

662-667

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Novel therapies in advanced renal cell carcinoma: management of adverse events from sorafenib and sunitinib.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous reactions to molecular targeted therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Gastroenterological palliative care]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An update on targeted therapy in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20631979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00105-010-1942-7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42969897&oldid=2205721071"